Table 5. Frequentist and Bayesian meta-analyses of within group and between group differences of dietary interventions on predicted ASCVD risk for each subgroup.

Predicted Risk, % (Frequentist)		White, lower-risk	White, higher-risk	African-American, lower-risk	African-American, higher-risk
Low CHO (within group)	Baseline	1.19 (0.90, 1.48)	4.88 (4.01, 5.74)	1.81 (1.35, 2.26)	6.38 (4.98, 7.78)
	Outcome	0.99 (0.72, 1.26)	4.03 (3.17, 4.88)	1.50 (1.04, 1.97)	5.08 (3.63, 6.53)
	Mean (95% CI)	-0.20 (-0.27, -0.13)	-0.85 (-1.10, -0.60)	-0.30 (-0.41, -0.19)	-1.30 (-1.72, -0.88)
	p	< 0.0001	< 0.0001	< 0.0001	< 0.0001
Low FAT (within group)	Baseline	1.22 (0.84, 1.60)	4.90 (3.89, 5.92)	1.85 (1.24, 2.46)	6.48 (4.71, 8.25)
	Outcome	1.13 (0.75, 1.51)	4.49 (3.44, 5.54)	1.74 (1.11, 2.37)	5.94 (4.13, 7.74)
	Mean (95% CI)	-0.10 (-0.17, -0.02)	-0.41 (-0.72, -0.10)	-0.11 (-0.24, 0.02)	-0.54 (-1.04, 0.04)
	p	0.01	0.01	0.086	0.036
Between Group Differences	Mean (95% CI)	-0.10 (-0.20, -0.01)	-0.44 (-0.83, -0.06)	-0.19 (-0.35, -0.03)	-0.76 (-1.38, -0.14)
	p	0.03	0.025	0.02	0.02
Predicted Risk, % (Bayesian)
Low CHO (within group)	Baseline	1.18 (0.89, 1.48)	4.89 (3.98, 5.81)	1.80 (1.33, 2.29)	6.38 (4.88, 7.84)
	Outcome	0.98 (0.70, 1.27)	4.01 (3.11, 4.91)	1.49 (1.00, 1.98)	5.03 (3.50,6.55)
	Mean (95% CrI)	-0.20 (-0.61, 0.21)	-0.88 (-2.15, 0.40)	-0.31 (-1.01, 0.37)	-1.35 (-3.48, 0.75)
	Probability Reduced Risk	84.1%	91.6%	82.1%	89.9%
Low FAT (within group)	Baseline	1.15 (0.79, 1.52)	4.83 (3.80,5.88)	1.80 (1.18, 2.42)	6.37 (4.58, 8.24)
	Outcome	1.05 (0.68, 1.42)	4.39 (3.34, 5.49)	1.67 (1.05, 2.30)	5.78 (3.99,7.66)
	Mean (95% CrI	-0.10 (-0.61, 0.40)	-0.44 (-1.94, 1.00)	-0.13 (-1.00, 0.73)	-0.59 (-3.19, 1.94)
	Probability Reduced Risk	66.7%	72.5%	62.1%	68.2%
Between Group Differences	Mean (95% CrI)	-0.11 (-0.21, 0.01)	-0.44 (-0.84, 0.02)	-0.19 (-0.37, -0.12)	-0.76 (-1.44, -0.06)
	Probability LoCHO Superior	98.1%	98.1%	98.1%	98.3%